Results 161 to 170 of about 461,523 (268)
Advances in cell sources, bioengineering, and manufacturing are reshaping the design of skin substitutes. This review highlights emerging strategies driving skin tissue engineering and discusses their potential to enable safer, reproducible, and clinically accessible skin substitutes for regenerative medicine.
Gilles Lemaître +7 more
wiley +1 more source
Human leukocyte antigen-G in solid tumors: from immunotolerance to immunotherapy. [PDF]
Lin A, Yan WH.
europepmc +1 more source
Biologically derived and hybrid nonviral nanovectors are examined as distinct but convergent design approaches. Integrating synthetic components with biologically functionalized membranes allows efficient interactions with complex cellular environments.
Clara Baldari +10 more
wiley +1 more source
Clinical Application of Peripheral Blood Biomarkers for Solid Tumors. [PDF]
Tu X, Tu M, Xu J.
europepmc +1 more source
Silicone breast implants are presented as a model system for understanding polymer permeation in vivo. Rather than representing material failure, “gel bleed” emerges from solution–diffusion transport‐mediated. By integrating polymer architecture, physicochemical transport, and biointerfacial processes, this review provides a unified framework that ...
D. Bouyer +12 more
wiley +1 more source
Adoptive cell therapies in solid tumors: current clinical landscape, challenges, and future directions. [PDF]
Rizkallah J +10 more
europepmc +1 more source
Upon contact with plasma, lipid nanoparticles (LNPs) rapidly acquire a protein corona (PC) that redefines their biological identity. In calcium‐containing environments, these coronated particles trigger the formation of a gel‐like plasma network, profoundly altering their transport properties and reducing their effective availability.
Serena Renzi +14 more
wiley +1 more source
AI-Driven Drug Discovery: Focus on Targets for Solid Tumors. [PDF]
Wu J +12 more
europepmc +1 more source

